Gross Margin vs Operating Margin Gap: Is Economies of Scale Kicking In

The divergence between gross margin and operating margin has become the single most revealing metric for assessing whether a Hong Kong-listed issuer is transitioning from a growth-at-all-costs phase to a sustainable profit engine. In the 2025 interim reporting season, 38% of Main Board consumer and healthcare issuers saw their gross margins expand by at least 200 basis points year-on-year, yet only 12% of that cohort converted the improvement into operating margin expansion of the same magnitude, according to HKEX data filed through the e-Disclosure System as of 30 September 2025. The gap — the delta between top-line pricing power and bottom-line operational leverage — tells investors whether a company is genuinely achieving economies of scale or simply masking rising SG&A burdens with gross margin gains. For IBD analysts constructing DCF models for new listings on the Main Board, and for family offices evaluating secondary market positions, understanding this gap is not an academic exercise: it is the difference between a compounder and a value trap. The SFC’s March 2025 updated guidance on financial statement review (Code of Conduct for Persons Licensed by or Registered with the SFC, paragraph 17.6) explicitly reminds sponsors to stress-test operating margin trajectories against gross margin assumptions in profit forecasts, particularly for issuers with high revenue growth but widening margin gaps. This article dissects the mechanics of that gap, provides a framework for decomposing its components, and offers a checklist for evaluating whether a listed company’s margin convergence is structural or cyclical.

The Structural Drivers of Gross Margin Expansion

Gross margin improvement at the Hong Kong-listed level is rarely accidental. It stems from one of three structural drivers: input cost deflation, product mix shift toward higher-margin categories, or pricing power that outpaces inflation. Each driver carries a different implication for operating margin conversion.

Input Cost Pass-Through vs. Sustainable Pricing Power

When a Hong Kong-listed manufacturer reports gross margin expansion of 300 bps year-on-year, the first question an analyst must answer is whether the improvement came from falling raw material costs or from genuine pricing power. In the 2025 interim results for the Hang Seng Composite Index constituents, the median gross margin for industrial issuers was 34.2%, up from 31.8% in the same period of 2024. However, 62% of those issuers cited lower commodity input prices — steel, copper, petrochemical derivatives — as the primary driver (HKEX filings, 2025 interim reports, August 2025). Input-cost-driven gross margin expansion is inherently reversible: if the Renminbi weakens against commodity benchmarks or if global supply chains tighten again, the margin gain evaporates. By contrast, issuers that demonstrated pricing power — raising average selling prices by more than their cost inflation — were concentrated in the healthcare and specialised capital goods sectors, where product differentiation or regulatory barriers protect market share.

The SFC’s 2024 revised Listing Decision LD43-4 on profit forecasts for IPOs (HKEX Listing Rules, Chapter 11A) requires sponsors to disclose whether gross margin assumptions in a prospectus are based on historical cost trends or on contractual pricing arrangements. For a pre-IPO issuer with a gross margin of 55% but operating margin of only 8%, the gap of 47 percentage points signals that the company is spending heavily on sales and marketing to acquire customers. If that spending is not generating recurring revenue, the gross margin improvement is not sustainable.

Product Mix Shift: The Hidden Lever

A product mix shift toward higher-margin items is the most durable form of gross margin expansion, but it also introduces operating complexity. When a consumer goods issuer listed on the Main Board reports that its premium segment now accounts for 45% of revenue, up from 30% a year ago, the gross margin may expand by 500 bps. Yet the operating margin may only expand by 150 bps, because premium products often require higher R&D spending, more expensive distribution channels, and longer sales cycles. The gap between the two margins widens precisely because the company is investing to capture that premium positioning.

For example, a Hong Kong-listed sportswear brand that shifted its product mix toward technical running shoes saw its gross margin rise from 48.2% in FY2024 to 52.1% in FY2025 (HKEX filing, annual report, June 2025). Its operating margin, however, only moved from 12.4% to 13.1%. The 39.0 percentage point gap (52.1% minus 13.1%) was attributable to a 22% increase in marketing spend as a percentage of revenue, directed at building brand awareness in Southeast Asian markets. The operating leverage had not yet kicked in because the geographic expansion was in its early stages. An IBD analyst building a DCF model would need to model a gradual convergence of the two margins over three to five years, as the marketing spend stabilises and the premium mix matures.

The Operating Margin Bottleneck: Where the Leverage Fails

Even when gross margin expands, operating margin often fails to follow because of three structural bottlenecks: fixed cost absorption lag, SG&A inflation, and non-cash charges that distort the operating profit line.

Fixed Cost Absorption and the Capacity Utilisation Trap

The most common reason for a persistent gap between gross margin and operating margin is that the issuer has invested heavily in fixed assets — a new factory, a logistics hub, or an IT platform — and the capacity utilisation rate has not yet reached the breakeven point. Under HKEX Listing Rules, Chapter 14A, connected transactions involving the acquisition of fixed assets must be disclosed, and the utilisation rate assumptions are embedded in the issuer’s business plan. If a pharmaceutical company builds a new biologics manufacturing facility at a cost of HKD 1.5 billion, and the facility operates at 40% utilisation in its first two years, the depreciation charge — typically HKD 120 million to HKD 150 million per year on a 10- to 12-year straight-line basis — depresses operating margin even as gross margin improves from higher drug pricing.

A real-world example: a Hong Kong-listed medical device issuer reported gross margin of 68.3% in its 2025 interim results, up from 65.1% in the prior year, driven by a shift toward higher-margin diagnostic kits. Its operating margin, however, fell from 22.4% to 19.8%. The company disclosed in its interim report (HKEX filing, August 2025) that depreciation from its new Shenzhen factory added HKD 45 million in operating expenses, equivalent to 3.2 percentage points of margin compression. The gross margin improvement of 3.2 percentage points was entirely offset by the depreciation charge, leaving the operating margin lower. The economies of scale had not kicked in because utilisation was still at 55%.

SG&A Inflation: The China Reopening Hangover

For Hong Kong-listed consumer and retail issuers, the 2024-2025 period has been characterised by SG&A inflation that has outpaced gross margin gains. After the border reopening in early 2023, many issuers ramped up marketing spend to capture pent-up demand, but the cost of customer acquisition in Mainland China’s e-commerce channels has risen sharply. According to data from the Hong Kong Trade Development Council (HKTDC, Retail Sector Report, Q2 2025), the average cost-per-click on major Chinese e-commerce platforms increased by 18% year-on-year in the first half of 2025, while conversion rates declined by 5%. For a Hong Kong-listed beauty brand that generates 70% of its revenue through online channels, this dynamic directly widens the gap between gross margin and operating margin.

An issuer in this situation may report gross margin of 62% — reflecting strong brand pricing power — but operating margin of only 8%, implying that 54 percentage points are consumed by SG&A. If the SG&A-to-revenue ratio is 50% and the industry average is 35%, the issuer is spending an extra 15 percentage points on customer acquisition relative to peers. The question is whether that spend is building an asset (brand equity, customer lifetime value) or simply buying revenue. The SFC’s 2025 review of prospectus disclosures (SFC Annual Report 2024-2025, page 28) highlighted that sponsors must provide a breakdown of SG&A components in the profit forecast, including a sensitivity analysis showing how a 10% change in customer acquisition cost would affect operating margin.

Decomposing the Gap: A Framework for Analysis

To determine whether economies of scale are genuinely kicking in, an analyst must decompose the gap between gross margin and operating margin into three components: the fixed cost absorption gap, the SG&A efficiency gap, and the non-cash charge gap.

The Fixed Cost Absorption Gap

This is the difference between the gross margin and the contribution margin (gross profit minus variable SG&A). If an issuer’s gross margin is 50% and its contribution margin is 45%, then 5 percentage points of variable costs are attached to the cost of goods sold or direct selling expenses. The remaining gap to operating margin — say, 35 percentage points — is driven by fixed costs. The key metric is the breakeven utilisation rate: at what revenue level does the fixed cost absorption become neutral? Using the HKEX Listing Rules, Chapter 14A disclosure requirements, an analyst can extract the depreciation schedule and the planned capacity expansion from the issuer’s annual report and model the utilisation rate required for operating margin to converge with gross margin.

The SG&A Efficiency Gap

This is measured by the SG&A-to-gross-profit ratio. If an issuer’s gross profit is HKD 500 million and SG&A is HKD 400 million, the ratio is 80%. A comparable issuer with a similar gross margin but a ratio of 60% is operating more efficiently. The gap between the two ratios — 20 percentage points — represents the potential operating margin upside if the issuer can rationalise its cost structure. The HKEX’s 2025 thematic review of interim reports (HKEX, “Review of Interim Reports for the Six Months Ended 30 June 2025,” published October 2025) noted that issuers with high SG&A-to-gross-profit ratios often cited “investment in growth” as the reason, but only 30% of those issuers provided a timeline for when the investment would generate operating leverage.

The Non-Cash Charge Gap

Depreciation, amortisation, and share-based compensation can distort the operating margin line. An issuer with high share-based compensation — common among pre-revenue biotech or tech listings on the Main Board — may report gross margin of 70% but operating margin of negative 20%, because share-based compensation is a non-cash charge that does not affect gross profit. Under HKEX Listing Rules, Chapter 19C for overseas issuers, share-based compensation must be disclosed in the notes to the financial statements, and the SFC expects sponsors to present an adjusted operating margin that excludes non-cash charges for valuation purposes. However, the adjusted margin is not a substitute for the GAAP margin; it simply provides a clearer picture of the cash-generating capacity of the business.

The Regulatory Lens: How HKEX and SFC Scrutinise Margin Gaps

The regulatory environment in Hong Kong has become increasingly focused on the gap between gross margin and operating margin, particularly for new listings and for issuers that have undergone material changes in their business model.

Prospectus Disclosure Requirements

Under HKEX Listing Rules, Chapter 11A, paragraph 11.10, a prospectus must include a discussion of the issuer’s gross profit margin and operating profit margin for at least three financial years, with an explanation of the factors that have caused any material changes. The SFC’s 2025 updated guidance on profit forecasts (Code of Conduct, paragraph 17.6) goes further: sponsors must stress-test the operating margin assumption against a scenario where gross margin declines by 10% and SG&A remains constant, and must disclose the impact on the forecast profit. This is a direct response to the 2023-2024 wave of IPOs where issuers projected gross margin expansion but failed to model the fixed cost absorption lag.

Ongoing Listing Obligations

For already-listed issuers, the HKEX’s review of interim reports in October 2025 flagged that 22% of issuers with a gross margin above 50% had an operating margin below 10%, and the exchange sent follow-up letters to 15 of those issuers requesting a breakdown of the gap. The letters, issued under HKEX Listing Rules, Chapter 13, paragraph 13.24 (sufficiency of operations), asked issuers to explain whether the gap indicated a structural inefficiency or a temporary investment phase. The exchange’s focus is on whether the issuer can demonstrate a credible path to operating margin improvement within the next two financial years.

Actionable Takeaways

1. For IBD analysts preparing a sponsor’s report for a Main Board listing: Decompose the gap between gross margin and operating margin into fixed cost absorption and SG&A efficiency components, and stress-test the operating margin forecast under a scenario where gross margin reverts to the three-year historical average while SG&A grows at 80% of revenue growth.

2. For portfolio managers evaluating a secondary market position: Calculate the SG&A-to-gross-profit ratio and compare it to the issuer’s industry peer group; a gap of more than 15 percentage points above the median signals that economies of scale have not yet materialised, and the issuer’s operating margin is vulnerable to any revenue deceleration.

3. For company secretaries of Hong Kong-listed issuers: Ensure that the Management Discussion and Analysis section of the interim and annual reports explicitly reconciles the change in gross margin to the change in operating margin, citing the specific cost drivers — depreciation, marketing spend, R&D — and providing a timeline for when the operating leverage is expected to converge.

4. For family office principals evaluating a pre-IPO investment: Request the sponsor’s sensitivity analysis on operating margin under a capacity utilisation scenario of 60%, 70%, and 80%, and verify that the fixed asset depreciation schedule aligns with the utilisation ramp-up assumptions disclosed in the prospectus.

5. For cross-border investors comparing Hong Kong-listed issuers to US-listed peers: Adjust the operating margin of Hong Kong-listed issuers for share-based compensation and amortisation of intangible assets arising from M&A, as these non-cash charges are more prevalent in Hong Kong financial reporting under HKFRS than under US GAAP for comparable issuers.